IRIS
TASSONE, PIERFRANCESCO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.170
EU - Europa 1.459
AS - Asia 280
Continente sconosciuto - Info sul continente non disponibili 24
SA - Sud America 21
OC - Oceania 12
AF - Africa 8
Totale 5.974
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.985
IT - Italia 588
SE - Svezia 385
GB - Regno Unito 278
CA - Canada 176
CN - Cina 96
IN - India 76
DE - Germania 40
RO - Romania 34
NL - Olanda 25
FR - Francia 23
EU - Europa 22
JO - Giordania 21
RU - Federazione Russa 19
IR - Iran 17
UA - Ucraina 15
PK - Pakistan 13
FI - Finlandia 11
BR - Brasile 10
AU - Australia 9
ES - Italia 9
JP - Giappone 8
KR - Corea 8
SG - Singapore 8
CL - Cile 7
MX - Messico 7
HK - Hong Kong 5
IE - Irlanda 5
LT - Lituania 5
PT - Portogallo 4
TW - Taiwan 4
AT - Austria 3
BD - Bangladesh 3
CH - Svizzera 3
CZ - Repubblica Ceca 3
ID - Indonesia 3
IL - Israele 3
LK - Sri Lanka 3
MA - Marocco 3
MY - Malesia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
PH - Filippine 3
SA - Arabia Saudita 3
A2 - ???statistics.table.value.countryCode.A2??? 2
CO - Colombia 2
GR - Grecia 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
PL - Polonia 2
TR - Turchia 2
ZA - Sudafrica 2
BO - Bolivia 1
DK - Danimarca 1
UY - Uruguay 1
VN - Vietnam 1
Totale 5.974
Salva come PNG Salva come JPEG
Città #
Chandler 906
Lawrence 383
Princeton 383
Chicago 235
London 235
Wilmington 223
Ottawa 163
Catanzaro 149
Ashburn 142
Des Moines 111
Beijing 49
Pune 35
Norwalk 32
Redwood City 30
Redmond 28
Rome 28
Boardman 27
Naples 18
New York 14
West Jordan 14
Amman 13
Horia 13
Mountain View 13
Timisoara 12
Augusta 11
Hanover 11
Helsinki 11
Reggio Calabria 11
Washington 11
Cosenza 10
Delhi 10
Zhengzhou 10
Ahmedabad 8
Irbid 8
Santo Stefano di Rogliano 8
Bari 7
Seattle 7
Settingiano 7
Spezzano della Sila 7
Los Angeles 6
Melito di Porto Salvo 6
Sezze 6
Shanghai 6
Ann Arbor 5
Cardiff 5
Kaunas 5
Leawood 5
Meppel 5
Milan 5
Oristano 5
Puteaux 5
Sacramento 5
Seoul 5
Siano 5
Singapore 5
Andover 4
Caserta 4
Clearwater 4
Decollatura 4
Frankfurt am Main 4
Hebei 4
Manchester 4
Melbourne 4
Nanjing 4
Palermo 4
Parma 4
Québec 4
San Antonio 4
San Jose 4
Seaham 4
Toronto 4
Acquaviva delle Fonti 3
Amsterdam 3
Banyumas 3
Castrovillari 3
Cetraro 3
Colombo 3
Esslingen am Neckar 3
Fayetteville 3
Ferrara 3
Genoa 3
Hefei 3
Hyderabad 3
Lamezia Terme 3
Madrid 3
Masera 3
Mileto 3
Oxford 3
Pachino 3
Paola 3
Treviso 3
Turin 3
Waterford 3
Agrigento 2
Apo 2
Aversa 2
Bogotá 2
Bologna 2
Brescia 2
Brighton 2
Totale 3.621
Salva come PNG Salva come JPEG
Nome #
Pharmacogenetics/Pharmacogenomics of Drug-Metabolizing Enzymes and Transporters 146
MiR-29b antagonizes the pro-inflammatory tumor-promoting activity of multiple myeloma-educated dendritic cells 51
A Novel Bispecific T-Cell Engager (CD1a x CD3ε) BTCE Is Effective against Cortical-Derived T Cell Acute Lymphoblastic Leukemia (T-ALL) Cells 48
A drug repurposing screening reveals a novel epigenetic activity of hydroxychloroquine. 48
Differential microRNAs expression profile in coronary thrombi from patients with no-reflow after primary PCI 42
Molecular and clinical types of plasma cell dyscrasias are associated with distinct expression patterns of long noncoding RNAs 42
MYC-MIR-22 REGULATORY LOOP MODULATES LENALIDOMIDE ACTIVITY IN MULTIPLE MYELOMA CELLS 42
Identifying prognostic markers for multiple myeloma through integration and analysis of MMRF-CoMMpass data 41
MIR-21 SUPPRESSION IMPAIRS TH17 RELATED BONE DISEASE IN MULTIPLE MYELOMA 39
Therapeutic afucosylated monoclonal antibody and bispecific T-cell engagers for T-cell acute lymphoblastic leukemia 39
miR-221/222 as biomarkers and targets for therapeutic intervention on cancer and other diseases: A systematic review 39
DMET-Analyzer: automatic analysis of Affymetrix DMET Data 38
Discovery, Functional Characterization and Therapeutic Targeting of Lnc-17-92 Metabolic Signaling in Multiple Myeloma 36
Raman Spectroscopic Stratification of Multiple Myeloma Patients Based on Exosome Profiling 35
A 13 mer LNA-i-miR-221 Inhibitor Restores Drug Sensitivity in Melphalan-Refractory Multiple Myeloma Cells 34
LNA-Gapmer Antisense Oligonucleotides Targeting the Oncogenic Lncrna MALAT1 Trigger Anti-Multiple Myeloma Activity By Proteasome Blockade 34
miR-21 antagonism abrogates Th17 tumor promoting functions in multiple myeloma 33
Modulation of Exosomal microRNA in patients with severe Aortic Stenosis after Transcatheter Aortic Valve Implantation (TAVI) 32
An interleukin-6 antagonist modified for bone targeting preserves anti-myeloma biological activity 32
Evidence of shared epitopic reactivity among independent B-cell clones in Chronic Lymphocytic Leukemia patients 32
Non-coding RNAs in cancer: Platforms and strategies for investigating the genomic "dark matter" 32
A 5 ' regulatory sequence containing two Ets motifs controls the expression of the Wiskott-Aldrich syndrome protein (WASP) gene in human hematopoietic cells 31
A p53-dependent tumor suppressor network is induced by selective miR-125a-5p inhibition in multiple myeloma cells in vitro 30
A peroxisome proliferator-activated receptor gamma (PPARG) polymorphism is associated with zoledronic acid-related osteonecrosis of the jaw in multiple myeloma patients: analysis by DMET microarray profiling 30
Impact of natural dietary agents on multiple myeloma prevention and treatment: molecular insights and potential for clinical translation. 30
Evidence of a founder mutation of BRCA1 in a highly homogeneous population from southern Italy with breast/ovarian cancer 30
Error-prone DNA repair pathways as determinants of immunotherapy activity: an emerging scenario for cancer treatment 30
Inhibition of EZH2 triggers the tumor suppressive miR-29b network in multiple myeloma 29
Involvement of multiple myeloma cell-derived exosomes in osteoclast differentiation 29
A novel monoclonal antibody recognizing human thymocytes and B-cell chronic lymphocytic leukemia cells 29
Exploiting MYC-induced PARPness to target genomic instability in multiple myeloma 29
Whole gene expression profiling shows a differential transcriptional response to CISPLATINUM in BRCA-1 defective versus BRCA1-reconstituted breast cancer cells 28
A35 SINGLE NUCLEOTIDE POLYMORPHISMS OF THE ABCG1 AND ABCC5 TRANSPORTER GENES CORRELATE TO IRINOTECAN-ASSOCIATED GASTROINTESTINAL TOXICITY IN COLORECTAL CANCER PATIENTS AS ASSESSED BY DMET MICROARRAY PROFILING 28
Serum Programmed death-ligand 1 (PD-L1) as biomarker or response for anti-PD-L1 immunotherapy 28
Gemcitabine, oxaliplatin, levofolinate, 5-fluorouracil, granulocyte-macrophage colony-stimulating factor, and interleukin-2 (GOLFIG) versus FOLFOX chemotherapy in metastatic colorectal cancer patients: The GOLFIG-2 multicentric open-label randomized phase III trial 27
Targeting PI3K and RAD51 in Barrett's Adenocarcinoma: Impact on DNA Damage Checkpoints, Expression Profile and Tumor Growth 27
Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis 27
Cytotoxic drugs up-regulate epidermal growth factor receptor (EGFR) expression in colon cancer cells and enhance their susceptibility to EGFR-targeted antibody-dependent cell-mediated-cytotoxicity (ADCC) 27
Second-line treatment of non-small cell lung cancer by biweekly gemcitabine and docetaxel plus /- granulocyte-macrophage colony stimulating factor and low dose aldesleukine 27
Allometric scaling approaches for predicting human pharmacokinetic of a locked nucleic acid oligonucleotide targeting cancer-associated miR-221 27
Pharmacogenomics biomarker discovery and validation for translation in clinical practice. 27
Mmrf-commpass data integration and analysis for identifying prognostic markers 27
Trabectedin triggers direct and NK-mediated cytotoxicity in multiple myeloma. 27
A systematic review and meta-analysis of randomized trials on the role of targeted therapy in the management of advanced gastric cancer: Evidence does not translate? 26
Mir-221/222 are promising targets for innovative anticancer therapy 26
Differential expression of UN1, early thymocyte-associated sialoglycoprotein, in breast normal tissue, benign disease and carcinomas 26
DmetTM genotyping: Tools for biomarkers discovery in the era of precision medicine 26
ACTIVATION OF GPER SIGNALING AS A POTENTIAL THERAPEUTIC STRATEGY AGAINST WALDENSTROM MACROGLOBULINEMIA 26
The First-In-Class Anti-AXL×CD3ε Pronectin™-Based Bispecific T-Cell Engager Is Active in Preclinical Models of Human Soft Tissue and Bone Sarcomas 25
Exploiting DNA Ligase III addiction of multiple myeloma by flavonoid Rhamnetin 25
Synthesis and preliminary evaluation of the anti-cancer activity on A549 lung cancer cells of a series of unsaturated disulfides. 25
Identification by differential display of cDNA sequences regulated during hematopoietic differentiation and in leukemias 25
Aberrant Glycosylation as Biomarker for Cancer: Focus on CD43 25
Purification and characterization of a human sialoglycoprotein antigen expressed in immature thymocytes and fetal tissues 24
UN1, a murine monoclonal antibody recognizing a novel human thymic antigen 24
A compendium of DIS3 mutations and associated transcriptional signatures in plasma cell dyscrasias 24
HLA class I, NKG2D and natural cytotoxicity receptors regulate multiple myeloma cell recognition by natural killer cells 24
[Magnesium salts in the treatment of ventricular tachycardia]. FT I sali di magnesio nel trattamento della tachicardia ventricolare. 24
Anti-MALAT1 synthetic oligonucleotides target the proteasome and exert anti-multiple myeloma activity 24
DMET-miner: Efficient learning of association rules from genotyping data for personalized medicine 24
HLA Expression Correlates to the Risk of Immune Checkpoint Inhibitor-Induced Pneumonitis 24
Autoimmune colitis and neutropenia in adjuvant anti-PD-1 therapy for malignant melanoma: efficacy of Vedolizumab, a case report 24
Integration of DNA Microarray with Clinical and Genomic Data 24
Novel therapeutic approaches based on the targeting of microenvironment-derived survival pathways in human cancer: Experimental models and translational issues 23
p38 mitogen-activated protein kinase inhibitor LY2228820 enhances bortezomib-induced cytotoxicity and inhibits osteoclastogenesis in multiple myeloma; therapeutic implications 23
Hereditary nonpolyposis colon cancer results from heritable defects in the MLH1, MSH2, PMS1 and PMS2 genes, which encode proteins involved in the mismatch repair process. In this work we report the identification of two novel germline mutations in the MLH1 gene from two unrelated HNPCC families. The two affected families do not fulfill the Amsterdam criteria. In family 1 we found a missense S93G mutation, which lies in a MLH1 domain critical for its MMR functions. In family 2 we found a two nucleotide insertion (AG) in position 523 from the AUG which determines an early stop codon at position 606 (codon 203). In both families the mutant alleles cosegregate with the cancer phenotype. 23
Epigenetic modifications in multiple myeloma: recent advances on the role of DNA and histone methylation 23
A high-affinity fully human anti-IL-6 mAb, 1339, for the treatment of multiple myeloma 23
DETECTION OF AN ANTIGENIC MARKER EXPRESSED BY PERIPHERAL-BLOOD MONOCYTES AND PLATELETS BY A NEW MONOCLONAL-ANTIBODY, UN8 23
CD69 expression on primitive progenitor cells and hematopoietic malignancies 23
Polymorphic variants in NR1I3 and UGT2B7 predict taxane neurotoxicity and have prognostic relevance in breast cancer patients: a case-control study. 23
A gene expression inflammatory signature specifically predicts multiple myeloma evolution and patients survival 23
Transcriptional regulation of the mismatch repair gene hMLH1 23
GOLFIG Chemo-Immunotherapy in Metastatic Colorectal Cancer Patients. A Critical Review on a Long-Lasting Follow-Up 23
Bergamot Polyphenols Improve Dyslipidemia and Pathophysiological Features in a Mouse Model of Non-Alcoholic Fatty Liver Disease 23
Pyrrolo[2′,3′:3,4]cyclohepta[1,2- d][1,2]oxazoles, a New Class of Antimitotic Agents Active against Multiple Malignant Cell Types 23
The farnesyltransferase inhibitor R115777 (ZARNESTRA®) enhances the pro-apoptotic activity of interferon-α through the inhibition of multiple survival pathways 22
Aggresome induction by proteasome inhibitor bortezomib and alpha-tubulin hyperacetylation by tubulin deacetylase(TDAC) inhibitor LBH589 are synergistic in myeloma cells 22
Canonical and noncanonical Hedgehog pathway in the pathogenesis of multiple myeloma 22
Tumor infiltration by chemokine receptor 7 (CCR7)(+) T-lymphocytes is a favorable prognostic factor in metastatic colorectal cancer 22
Epstein-Barr Virus Nuclear Antigen 2 transactivates the Long Terminal Repeat of Human Immunodeficiency Virus Type 1 22
Treatment with an adenoviral vector expressing the IL-6 receptor superantagonist sant7 compared with the treatment with the recombinant sant7 protein in MM cell lines 22
Biochemical modification of an Interleukin-6 antagonist to target myeloma cells in the bone marrow microenvironment 22
A clinically relevant SCID-hu in vivo model of human multiple myeloma 22
Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients 22
JunB is a key regulator of multiple myeloma bone marrow angiogenesis 22
miR-22 suppresses DNA ligase III addiction in multiple myeloma 22
Replacement of miR-155 Elicits Tumor Suppressive Activity and Antagonizes Bortezomib Resistance in Multiple Myeloma. 21
Mir-34: a new weapon against cancer? 21
Drugging the lncRNA MALAT1 via LNA gapmeR ASO inhibits gene expression of proteasome subunits and triggers anti-multiple myeloma activity. 21
MLN120B, a novel lkappaB kinase beta inhibitor, blocks multiple myeloma cell growth in vitro and in vivo 21
Targeting miR-21 Inhibits In Vitro and In Vivo Multiple Myeloma Cell Growth 21
BRCA1 expression modulates chemosensitivity of BRCA1-defective HCC1937 human breast cancer cells 21
[Extended subcutaneous mastectomy. A new type of operation in non-destructive surgery of breast neoplasms]. FT La mastectomia sottocutanea allargata. Un nuovo tipo d'intervento nella chirurgia non demolitiva della neoplasia mammaria. 21
Proteomic pattern of BRCA1-deficient and reconstituted HCC1937 breast cancer cells: correlation with sensitivity profile to mitotic spindle poisoning drugs 21
Differential sensitivity of BRCA1-mutated HCC1937 human breast cancer cells to microtubule-interfering agents 21
Pembrolizumab-Induced Psoriasis in Metastatic Melanoma: Activity and Safety of Apremilast, a Case Report 21
Un raro caso di sindrome di Greig 21
Early blood rise in auto-antibodies to nuclear and smooth muscle antigens is predictive of prolonged survival and autoimmunity in metastatic-non-small cell lung cancer patients treated with PD-1 immune-check point blockade by nivolumab 21
Safety and activity of the first-in-class locked nucleic acid (LNA) miR-221 selective inhibitor in refractory advanced cancer patients: a first-in-human, phase 1, open-label, dose-escalation study 20
Totale 2.847
Salva come PNG Salva come JPEG
Categoria #
all - tutte 87.224
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 87.224
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020350 0 0 0 20 75 9 13 11 9 16 45 152
2020/2021516 51 20 12 23 63 53 33 26 73 82 65 15
2021/20221.151 27 6 17 333 87 20 29 249 114 97 149 23
2022/20232.838 787 108 110 204 299 234 23 198 425 171 228 51
2023/20241.397 347 158 127 110 104 379 45 61 13 51 2 0
Totale 6.252